Clinical Trial Update: VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing valsartan to irbesartan for reducing predialysis systolic blood pressure in patients with mild-to-moderate hypertension on long-term h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Drugs mentioned

• AVAPRO (irbesartan)
• DIOVAN (valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED